Analysis of major histocompatibility complex class I expression on Reed-Sternberg cells in relation to the cytotoxic T-cell response in Epstein-Barr virus-positive and-negative Hodgkin's Disease

Blood

Volumn 87, Issue 9, 1996, Pages 3844-3851

  Oudejans, J J ^a   Jiwa, N M ^b   Kummer, J A ^b   Horstman, A ^b   Vos, W ^b   Baak, J P A ^b   Kluin, Ph M ^b   Van Der Valk, P ^b   Walboomers, J M M ^b   Meijer, C J L M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; FEMALE; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REED STERNBERG CELL; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; ANTIGEN PRESENTATION; CHILD; FEMALE; HERPESVIRUS 4, HUMAN; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; REED-STERNBERG CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0029935374     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3844.bloodjournal8793844     Document Type: Article

References (54)

1. Kadin ME: Hodgkin's disease. Immunobiology and pathogenesis, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams and Wilkins, 1992, p 535
2. Herbst H, Niedobitek G: Epstein-Barr virus in Hodgkin's disease. Epstein-Barr Virus Report 1:31, 1994
3. Deacon EM, Pallesen G, Nieboditek G, Crocker J, Brooks L, Rickinson AB, Young LS: Epstein-Barr virus and Hodgkin's disease: Transcriptional analysis of virus latency in the malignant cells. J Exp Med 177:339, 1993
4. Joske DJL, Emery-Goodman A, Bachmann E, Bachmann F, Odermatt B, Knecht H: Epstein-Barr virus burden in Hodgkin's disease is related to membrane protein gene expression but not to active viral replication. Blood 80:2610, 1992
5. Herbst H, Dallenbach F, Hummel M, Niedobitek G, Pileri S, Mueller-Lantzsch N, Stein H: Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc Natl Acad Sci USA 88:4766, 1991
6. Grasser FA, Murray PG, Kremmer E, Klein K, Remberger K, Feiden W, Reynolds G, Niedobitek G, Young LS, Mueller-Lantzsch N: Monoclonal antibodies directed against the Epstein-Barr virus-encoded nuclear antigen 1 (EBNA1): Immunohistologic detection of EBNA1 in the malignant cells of Hodgkin's disease. Blood 84:3792, 1994
7. Masucci M, Ernberg I: Epstein-Barr virus: Adaptation to a life within the immune system. Trends Microbiol 2:125, 1994
8. Khanna R, Burrows SR, Kurilla MG, Jacob CA, Misko IS, Sculley TB, Kieff E, Moss DJ: Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: Implications for vaccine development. J Exp Med 176:169, 1992
9. Murray R, Kurilla M, Brooks J, Thomas W, Rowe M, Kieff E, Rickinson A: Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): Implications for the immune control of EBV-positive malignancies. J Exp Med 176:157, 1992
10. Slivnick DJ, Ellis TM, Nawrocki JF, Fisher RI. The impact of Hodgkin's disease on the immune system. Semin Oncol 17:673, 1990
11. Levy RA, Kaplan HS: Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med 290:181, 1974
12. Engleman EG, Benike CJ, Hoppe RT, Kaplan HS, Berberich FR: Autologous mixed lymphocyte reaction in patients with Hodgkin's disease. Evidence for a T cell defect. J Clin Invest 66:149, 1980
13. Ford RJ, Tsao J, Kouttab NM, Sahasrabuddhe CG, Metha SR: Association of an interleukin abnormality with the T-cell defect in Hodgkin's disease. Blood 64:386, 1984
14. Kummer JA, Kamp AM, van Katwijk M, Brakenhof JP, Radosevic K, van Leeuwen AM, Borst J, Verwey CL, Hack CE: Production and characterization of monoclonal antibodies raised against recombinant human granzymes A and B and showing cross reactions with the natural proteins. J Immunol Methods 163:77, 1993
15. Shiver JW, Lishan SU, Henkart PA: Cytotoxicity with target DNA breakdown by rat basophilic leukaemia cells expressing both cytolysin and granzyme A. Cell 71:315, 1992
16. Heusel JW, Wesselschrmdt RL, Shresta S, Russell JH, Ley TJ: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogenic target cells. Cell 76:977, 1994
17. Garcia-Sanz JA, Macdonald HR, Jenne DE, Tschopp J, Nabholz M: Cell specificity of granzyme gene expression. J Immunol 145:3111, 1990
18. Monaco JJ: A molecular model of MHC class-I-restricted antigen presentation. Immunol Today 13:173, 1992
19. Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, Meijer CJLM, Walboomers JMM: Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas. J Exp Med 179-335, 1994
20. Trowsdale J, Hanson I, Mockridge I, Beck S, Townsend A, Kelly A: Sequences encoded in the class II region of the MHC related to the ABC superfamily of transporters. Nature 348:741, 1990
21. Paul WE, Seder RA: Lymphocyte responses and cytokines. Cell 76:241, 1994
22. Biron CA: Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 6:530, 1994
23. Unanue, ER: Cellular studies on antigen presentation by class II MHC molecules. Curr Opin Immunol 4:63, 1992
24. Glew SS, Duggan-Keen M, Cabrera T, Stern PL: HLA class II antigen expression in human papillomavirus-associated cervical cancer. Cancer Res 52:4009, 1992
25. Lukes RJ, Craver LF, Hall TC, Rappaport H, Ruben P: Report of the nomenclature committee. Cancer Res 26:1311, 1966
26. Carbonne PP, Kaplan HS, Musschof K, Smithers DW: Report of the committee on Hodgkin's disease staging classification. Cancer Res 31:1860, 1971
27. Jiwa NM, Kanavaros P, van der Valk P, Walboomers JMM, Horstman A, Vos W, Mullink H, Meijer CJLM: Expression of c-myc and bcl-2 oncogene products in Reed Sternberg cells independent of presence for EBV. J Clin Pathol 46:211, 1993
28. Jiwa NM, Oudejans JJ, Dukers DF, Vos W, Horstman A, van der Valk P, Middeldorp JM, Kluin PhM, Walboomers JMM, Meijer CJLM: Immunohistochemical demonstration of different latent membrane protein-1 epitopes of Epstein-Barr virus in lymphoproliferative diseases. J Clin Pathol 48:438, 1995
29. Stam NJ, Vroom TM, Peters PJ, Pastoors EB, Ploegh HL: HLA-A and HLA-B-specific monoclonal antibodies reactive with free heavy chains in Western biots, in formalin fixed, paraffin embedded tissue sections and in cryo-immuno-electron microscopy. Int Immunol 2:113, 1990
30. Yoshino T, Mukuzono H, Aoki H, Takahashi K, Takeuchi T. Kubonishi I, Ohtsuki Y, Motoi M, Akagi T: A novel monoclonal antibody (OPD4) recognizing a helper/inducer T cell subset. Am J Pathol 134:1339, 1989
31. Poppema S, Lai R, Visser L: Monoclonal antibody OPD4 is reactive with CD45RO, but differs from UCHL1 by the absence of monocyte reactivity. Am J Pathol 139:725, 1991
32. Kummer JA, Kamp AM, Tadema TM, Vos W, Meijer CJLM, Hack E: Localization and identification of granzymes A and B expressing cells in normal human lymphoid tissue and peripheral blood. Clin Exp Immunol 100:164, 1995
33. Merchentaler I, Stankovics J, Gallyas F: A highly sensitive one-step method for silver intensification of the nickel-diaminobenzidine end product of peroxidase reaction. J Histochem Cytochem 37:1563, 1989
34. Jiwa NM, Oudejans JJ, Bai MC, van den Brule AJC, Horstman A, Vos W, van der Valk P, Kluin PhM, Watboomers JMM, Meijer CJLM: Expression of bcl-2 protein and transcription of the Epstein-Barr virus bcl-2 homologue BHRF1 in Hodgkin's disease: Implications for different pathogenic mechanisms. Histopathology 26:547, 1995
35. Fleege JC, van Diest PJ, Baak JPA: Computer assisted efficiency testing of different sampling methods for selective nuclear graphic tablet morphometry. Lab Invest 63:270, 1990
36. Poppema S, Visser L: Absence of HLA class I expression by Reed-Sternberg cells. Am J Pathol 145:37, 1994
37. Rowlan-Jones S, Powis SH, Sutton J, Mockridge I, Gotch FM, Murray N, Hill AB, Rosenberg WM, Trowsdale J, McMichael AJ: An antigen processing polymorphism revealed by HLA-B8-restricted cytotoxic T lymphocytes which does not correlate with TAP gene polymorphism. Eur J Immunol 23:1999, 1993
38. Lee SP, Thomas WA, Murray RJ, Khanim F, Kaur S, Young LS, Rowe M, Kurilla M, Rickinson AB: HLA A2.1 restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2. J Virol 67:7428, 1993
39. Thorley-Lawson DA, Israelson ES: Generation of specific cytotoxic T cells with a fragment of the Epstein-Barr virus encoded p63/latent membrane protein. Proc Natl Acad Sci USA 84:5384, 1987
40. De Campos-Lima PO, Torsteinsdottir S, Cuoma L, Klein G, Sulitzeana D, Masucci G: Antigen processing and presentation by EBV carrying cell lines: Cell phenotypes dependence and influence of the EBV encoded LMP1. Int J Cancer 53:856, 1993
41. Rowe M, Khanna R, Jacob CA, Argaet V, Kelly A, Powis S, Belich M, Croom-Carter D, Lee S, Burrows SR, Trowsdale J, Moss DJ, Rickinson AB: Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: Coordinate up-regulation of peptide transporters and HLA-class I antigen expression. Eur J Immunol 25:1374, 1995
42. Frisan T, Sjoberg J, Dolcetti R, Boiocchi M, De Re V, Carbone A, Brautbar C, Battat S, Biberfeld P, Eckman M, Öst A, Christensson B, Sundström C, Bjôkholm M, Pisa P, Masucci MG: Local suppression of Epstein-Barr virus (EBV)-specific cytotoxicity in biopsies of EBV-positive Hodgkin's disease. Blood 86:1493, 1995
43. Trivedi P, Hu L, Chen F, Christensson B, Masucci M, Klein G, Winberg G: The EBV encoded membrane protein LMP1 from a nasopharyngeal carcinoma is nonimmunogenic in a murine model system, in contrast to a B-cell derived homologue. Eur J Cancer 30A:84, 1994
44. Knecht H, Bachmann E, Brousset P, Sandvej K, Nadal D, Bachmann F, Odermatt BF, Delsol G, Pallesen G: Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937, 1993
45. Modlin RL, Nutman TB: Type 2 cytokines and negative immune regulation in human infections. Curr Opinion Immunol 5:511, 1993
46. Taga K, Tosato G: IL-10 inhibits human T-cell proliferation and IL-2 production. J Immunol 148:1143, 1992
47. Ding L, Shevach EM: IL-10 inhibits mitogen induced T-cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 148:3133, 1992
48. Matsuda M, Salazar F, Petersson M, Masucci G, Hansson J, Pisa P, Zhang QJ, Masucci MG, Kiessling R: Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression. J Exp Med 180:2371, 1994
49. Kerhl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Spom MB, Fauci AS: Production of transforming growth factor-beta by human T-lymphocytes and its potential role in the regulation of T-cell growth. J Exp Med 163:1037, 1986
50. Rook AH, Kerhl JH, Wakefield LM, Roberts AB, Spom MB, Burlington DB, Lane HC, Fauci AS: Effects of transforming growth factor B on the functions of natural killer cells: Depressed cytolytic activity and blunting of interferon responsiveness. J Immunol 136:3916, 1986
51. Newcom SR, Kadin ME, Ansari AA, Diehl V: L-428 nodular sclerosing Hodgkin's cell secretes a unique transforming growth factor-beta active at physiologic pH. J Clin Invest 83:1915, 1988
52. Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG: The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines. Int J Cancer 57:240, 1994
53. Moore KW, Vieira P, Fiorentina DF, Trounstine ML, Khna TA, Mosmann TR: Homology of cytokine synthesis inhibitory factor (IL-IO) to the Epstein-Barr virus gene BCRF1. Science 248:1230, 1990
54. Ohshima K, Suzumiya I, Akamatu M, Takeshita M, Kikuchi M: Human and viral interleukin-10 in Hodgkin's disease, and its influence on CD4+ and CD8+ T lymphocytes. Int J Cancer 62:5, 1995